Pentamidine inhibits prostate cancer progression via selectively inducing mitochondrial DNA depletion and dysfunction
Open Access
- 13 November 2019
- journal article
- research article
- Published by Wiley in Cell Proliferation
- Vol. 53 (1) , e12718
Abstract
Objectives: We investigated the anti‐cancer activity of pentamidine, an anti‐protozoal cationic aromatic diamidine drug, in prostate cancer cells and aimed to provide valuable insights for improving the efficacy of prostate cancer treatment.Materials and methods: Prostate cancer cell lines and epithelial RWPE‐1 cells were used in the study. Cell viability, wound‐healing, transwell and apoptosis assays were examined to evaluate the influences of pentamidine in vitro. RNA‐seq and qPCR were performed to analyse changes in gene transcription levels upon pentamidine treatment. Mitochondrial changes were assessed by measuring mitochondrial DNA content, morphology, membrane potential, cellular glucose uptake, ATP production and ROS generation. Nude mouse xenograft models were used to test anti‐tumour effects of pentamidine in vivo.Results: Pentamidine exerted profound inhibitory effects on proliferation, colony formation, migration and invasion of prostate cancer cells. In addition, the drug suppressed growth of xenograft tumours without exhibiting any obvious toxicity in nude mice. Mechanistically, pentamidine caused mitochondrial DNA content reduction and induced mitochondrial morphological changes, mitochondrial membrane potential dissipation, ATP level reduction, ROS production elevation and apoptosis in prostate cancer cells.Conclusions: Pentamidine can efficiently suppress prostate cancer progression and may serve as a novel mitochondria‐targeted therapeutic agent for prostate cancer.Keywords
Funding Information
- National Natural Science Foundation of China (81872406, 81630073, 81572832, 81874174)
This publication has 53 references indexed in Scilit:
- High mitochondria content is associated with prostate cancer disease progressionMolecular Cancer, 2013
- Pro-apoptotic activity of α-bisabolol in preclinical models of primary human acute leukemia cellsJournal of Translational Medicine, 2011
- DNA methylation and cellular reprogrammingTrends in Cell Biology, 2010
- Cytoprotective Mitochondrial Chaperone TRAP-1 As a Novel Molecular Target in Localized and Metastatic Prostate CancerThe American Journal of Pathology, 2010
- Prostate cancer regulatory networksJournal of Cellular Biochemistry, 2009
- Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial FissionJournal of Biological Chemistry, 2009
- Antiparasitic compounds that target DNABiochimie, 2008
- Accumulation and Intracellular Distribution of Antitrypanosomal Diamidine Compounds DB75 and DB820 in African TrypanosomesAntimicrobial Agents and Chemotherapy, 2006
- A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary MedicineAnnual Review of Genetics, 2005
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004